The Evidence-Based Drug Policy Act of 2025 seeks to facilitate research on cannabis by easing restrictions imposed by its Schedule I status. Introduced by Reps. Dina Titus and Ilhan Omar, the bill aims to allow policymakers to base legislation on factual data regarding cannabis usage, which has grown significantly in the U.S. Despite debates about its Schedule I classification, proponents argue that cannabis is widely used for medical purposes. The bill could potentially gain bipartisan support and transform how cannabis research is conducted federally.
"We need drug policy to follow the science and reflect the reality on the ground in states across the country." - Ilhan Omar
"The EBDPA would be simple to enact. It repeals sections that forbid federal funds from going towards research of schedule I substances." - Article Summary
"Medical cannabis proponents point out that cannabis's federal schedule I status is contradictory, given that patients throughout the US already use cannabis for medical purposes." - Article Summary
"This bill is a modest proposal and it might be possible for it to gain the bipartisan support it needs to pass." - Katharine Neill Harris
Collection
[
|
...
]